Cancer: a major cardiac comorbidity with implications on cardiovascular metabolism

Cardiovascular diseases have multifactorial causes. Classical cardiovascular risk factors, such as arterial hypertension, smoking, hyperlipidemia and diabetes associate with the development of vascular stenoses and coronary heart disease. Further comorbidities and its impact on cardiovascular metabo...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Finke, Daniel (VerfasserIn) , Heckmann, Markus B. (VerfasserIn) , Frey, Norbert (VerfasserIn) , Lehmann, Lorenz (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 26 November 2021
In: Frontiers in physiology
Year: 2021, Jahrgang: 12, Pages: 1-12
ISSN:1664-042X
DOI:10.3389/fphys.2021.729713
Online-Zugang:Verlag, kostenfrei, Volltext: https://doi.org/10.3389/fphys.2021.729713
Verlag, kostenfrei, Volltext: https://www.frontiersin.org/articles/10.3389/fphys.2021.729713/full
Volltext
Verfasserangaben:Daniel Finke, Markus B. Heckmann, Norbert Frey and Lorenz H. Lehmann

MARC

LEADER 00000caa a2200000 c 4500
001 178226728X
003 DE-627
005 20230426163146.0
007 cr uuu---uuuuu
008 211215s2021 xx |||||o 00| ||eng c
024 7 |a 10.3389/fphys.2021.729713  |2 doi 
035 |a (DE-627)178226728X 
035 |a (DE-599)KXP178226728X 
035 |a (OCoLC)1295644559 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Finke, Daniel  |d 1988-  |e VerfasserIn  |0 (DE-588)1148566899  |0 (DE-627)1008764876  |0 (DE-576)496329553  |4 aut 
245 1 0 |a Cancer  |b a major cardiac comorbidity with implications on cardiovascular metabolism  |c Daniel Finke, Markus B. Heckmann, Norbert Frey and Lorenz H. Lehmann 
264 1 |c 26 November 2021 
300 |a 12 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 15.12.2021 
520 |a Cardiovascular diseases have multifactorial causes. Classical cardiovascular risk factors, such as arterial hypertension, smoking, hyperlipidemia and diabetes associate with the development of vascular stenoses and coronary heart disease. Further comorbidities and its impact on cardiovascular metabolism have gotten more attention recently. Thus, also cancer biology may affect the heart, apart from cardiotoxic side effects of chemotherapies. Cancer is a systemic disease which primarily leads to metabolic alterations within the tumor. An emerging number of preclinical and clinical studies focuses on the interaction between cancer and a maladaptive crosstalk to the heart. Cachexia and sarcopenia can have dramatic consequences for many organ functions, including cardiac wasting and heart failure. These complications significantly increase mortality and morbidity of heart failure and cancer patients. There are concurrent metabolic changes in fatty acid oxidation and glucose utilization in heart failure as well as in cancer, involving central molecular regulators, such as PGC-1. Further, specific inflammatory cytokines (IL-1, IL-6, TNF-, INF-), non-inflammatory cytokines (myostatin, SerpinA3, Ataxin-10) and circulating metabolites (D2-HG) may mediate a direct and maladaptive crosstalk of both diseases. Additionally, cancer therapies such as anthracyclines and angiogenesis inhibitors target common metabolic mechanisms in cardiomyocytes and malignant cells. This review focuses on cardiovascular, cancerous and cancer therapy-associated alterations on the systemic and cardiac metabolic state. 
700 1 |a Heckmann, Markus B.  |d 1986-  |e VerfasserIn  |0 (DE-588)1120448077  |0 (DE-627)873392434  |0 (DE-576)480359253  |4 aut 
700 1 |a Frey, Norbert  |e VerfasserIn  |0 (DE-588)141244976  |0 (DE-627)625824075  |0 (DE-576)322969514  |4 aut 
700 1 |a Lehmann, Lorenz  |d 1980-  |e VerfasserIn  |0 (DE-588)131855212  |0 (DE-627)515807184  |0 (DE-576)298796104  |4 aut 
773 0 8 |i Enthalten in  |t Frontiers in physiology  |d Lausanne : Frontiers Research Foundation, 2007  |g 12(2021) vom: 26. Nov., Artikel-ID 729713, Seite 1-12  |h Online-Ressource  |w (DE-627)631498788  |w (DE-600)2564217-0  |w (DE-576)32655095X  |x 1664-042X  |7 nnas  |a Cancer a major cardiac comorbidity with implications on cardiovascular metabolism 
773 1 8 |g volume:12  |g year:2021  |g day:26  |g month:11  |g elocationid:729713  |g pages:1-12  |g extent:12  |a Cancer a major cardiac comorbidity with implications on cardiovascular metabolism 
856 4 0 |u https://doi.org/10.3389/fphys.2021.729713  |x Verlag  |x Resolving-System  |z kostenfrei  |3 Volltext 
856 4 0 |u https://www.frontiersin.org/articles/10.3389/fphys.2021.729713/full  |x Verlag  |z kostenfrei  |3 Volltext 
951 |a AR 
992 |a 20211215 
993 |a Article 
994 |a 2021 
998 |g 131855212  |a Lehmann, Lorenz  |m 131855212:Lehmann, Lorenz  |d 910000  |d 910100  |d 50000  |e 910000PL131855212  |e 910100PL131855212  |e 50000PL131855212  |k 0/910000/  |k 1/910000/910100/  |k 0/50000/  |p 4  |y j 
998 |g 141244976  |a Frey, Norbert  |m 141244976:Frey, Norbert  |d 910000  |d 910100  |e 910000PF141244976  |e 910100PF141244976  |k 0/910000/  |k 1/910000/910100/  |p 3 
998 |g 1120448077  |a Heckmann, Markus B.  |m 1120448077:Heckmann, Markus B.  |d 910000  |d 910100  |e 910000PH1120448077  |e 910100PH1120448077  |k 0/910000/  |k 1/910000/910100/  |p 2 
998 |g 1148566899  |a Finke, Daniel  |m 1148566899:Finke, Daniel  |d 910000  |d 910100  |e 910000PF1148566899  |e 910100PF1148566899  |k 0/910000/  |k 1/910000/910100/  |p 1  |x j 
999 |a KXP-PPN178226728X  |e 4020501122 
BIB |a Y 
SER |a journal 
JSO |a {"person":[{"display":"Finke, Daniel","given":"Daniel","family":"Finke","role":"aut"},{"given":"Markus B.","display":"Heckmann, Markus B.","family":"Heckmann","role":"aut"},{"family":"Frey","role":"aut","display":"Frey, Norbert","given":"Norbert"},{"given":"Lorenz","display":"Lehmann, Lorenz","role":"aut","family":"Lehmann"}],"relHost":[{"origin":[{"publisher":"Frontiers Research Foundation","dateIssuedKey":"2007","dateIssuedDisp":"2007-","publisherPlace":"Lausanne"}],"type":{"bibl":"periodical","media":"Online-Ressource"},"disp":"Cancer a major cardiac comorbidity with implications on cardiovascular metabolismFrontiers in physiology","language":["eng"],"part":{"pages":"1-12","text":"12(2021) vom: 26. Nov., Artikel-ID 729713, Seite 1-12","year":"2021","extent":"12","volume":"12"},"title":[{"title":"Frontiers in physiology","title_sort":"Frontiers in physiology"}],"note":["Gesehen am 24.05.23"],"recId":"631498788","id":{"issn":["1664-042X"],"zdb":["2564217-0"],"eki":["631498788"]},"name":{"displayForm":["Frontiers Research Foundation"]},"pubHistory":["2007 -"],"physDesc":[{"extent":"Online-Ressource"}]}],"physDesc":[{"extent":"12 S."}],"name":{"displayForm":["Daniel Finke, Markus B. Heckmann, Norbert Frey and Lorenz H. Lehmann"]},"id":{"doi":["10.3389/fphys.2021.729713"],"eki":["178226728X"]},"recId":"178226728X","note":["Gesehen am 15.12.2021"],"title":[{"title":"Cancer","title_sort":"Cancer","subtitle":"a major cardiac comorbidity with implications on cardiovascular metabolism"}],"language":["eng"],"origin":[{"dateIssuedKey":"2021","dateIssuedDisp":"26 November 2021"}],"type":{"bibl":"article-journal","media":"Online-Ressource"}} 
SRT |a FINKEDANIECANCER2620